[go: up one dir, main page]

DK166828B1 - Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel - Google Patents

Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel Download PDF

Info

Publication number
DK166828B1
DK166828B1 DK356984A DK356984A DK166828B1 DK 166828 B1 DK166828 B1 DK 166828B1 DK 356984 A DK356984 A DK 356984A DK 356984 A DK356984 A DK 356984A DK 166828 B1 DK166828 B1 DK 166828B1
Authority
DK
Denmark
Prior art keywords
ganglioside
gm1p
mono
sialo
aqueous solution
Prior art date
Application number
DK356984A
Other languages
Danish (da)
English (en)
Other versions
DK356984D0 (da
DK356984A (da
Inventor
Ezio Tubaro
Giovanni Cavallo
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK356984D0 publication Critical patent/DK356984D0/da
Publication of DK356984A publication Critical patent/DK356984A/da
Application granted granted Critical
Publication of DK166828B1 publication Critical patent/DK166828B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK356984A 1983-07-21 1984-07-20 Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel DK166828B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT4872483 1983-07-21
IT48724/83A IT1168205B (it) 1983-07-21 1983-07-21 Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione

Publications (3)

Publication Number Publication Date
DK356984D0 DK356984D0 (da) 1984-07-20
DK356984A DK356984A (da) 1985-01-22
DK166828B1 true DK166828B1 (da) 1993-07-19

Family

ID=11268264

Family Applications (1)

Application Number Title Priority Date Filing Date
DK356984A DK166828B1 (da) 1983-07-21 1984-07-20 Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel

Country Status (9)

Country Link
US (2) US4728641A (it)
EP (1) EP0136438B1 (it)
JP (1) JPS6084296A (it)
AT (1) ATE75480T1 (it)
DE (1) DE3485680D1 (it)
DK (1) DK166828B1 (it)
ES (1) ES534494A0 (it)
HU (1) HU198091B (it)
IT (1) IT1168205B (it)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660557A5 (fr) * 1984-10-26 1987-05-15 Nestle Sa Composition anti-bacterienne et procede de preparation de ses constituants actifs.
DK17885D0 (da) * 1985-01-14 1985-01-14 Karlsson Karl Anders Antiviralt middel
JPH0653764B2 (ja) * 1985-07-31 1994-07-20 三井東圧化学株式会社 モノシアロガングリオシドの製造法
EP0249008B1 (de) * 1986-05-09 1993-09-15 Pulverer, Gerhard, Prof. Dr.Dr.h.c. Verwendung von spezifischen Monosacchariden zur Herstellung eines Arzneimittels zur Verhinderung von Metastasen maligner Tumore
IT1208751B (it) * 1986-06-30 1989-07-10 Fidia Farmaceutici Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali
EP0508493A1 (en) * 1986-08-06 1992-10-14 Mect Corporation Ganglioside related compounds and method of producing the same
IT1212041B (it) * 1987-11-02 1989-11-08 Fidia Farmaceutici Gangliosidi esteri interni come agenti terapeutici capaci di eliminare il dolore nelle neuropatie periferiche
AU7153991A (en) * 1989-12-13 1991-07-18 Glycomed Incorporated Synthesis of rotavirus receptor saccharides
WO1991008747A1 (en) * 1989-12-13 1991-06-27 Glycomed Incorporated Synthetic receptor molecules recognizable by a rotavirus
WO1993002686A1 (en) * 1991-07-31 1993-02-18 The Regents Of The University Of California Gangliosides with immunosuppressive ceramide moieties
US5936076A (en) * 1991-08-29 1999-08-10 Kirin Beer Kabushiki Kaisha αgalactosylceramide derivatives
DE4204907A1 (de) * 1992-02-14 1993-08-19 Reutter Werner Neuartige glykokonjugate mit n-substituierten neuraminsaeuren als mittel zur stimulierung des immunsystems
TW261533B (it) * 1992-07-16 1995-11-01 Kirin Brewery
WO1994009020A1 (fr) * 1992-10-22 1994-04-28 Kirin Beer Kabushiki Kaisha Nouveau shingoglycolipide et son utilisation
DE69416306T2 (de) * 1993-04-15 1999-06-17 Kirin Beer K.K., Tokio/Tokyo Sphingoglycolipid und verwendung davon
DE19602108A1 (de) * 1996-01-22 1997-07-24 Beiersdorf Ag Gegen Bakterien, Parasiten, Protozoen, Mycota und Viren wirksame Substanzen
US5747476A (en) 1996-07-17 1998-05-05 Mortar & Pestle Veterinary Pharmacy, Inc. Treatment of equine protozoal myeloencephalitis
DE19643585A1 (de) * 1996-10-22 1998-04-23 Beiersdorf Ag Antiadhäsive Sphingolipide
WO2002018401A2 (en) * 2000-09-01 2002-03-07 Neuronyx, Inc. Novel synthetic gangliosides
AU2001288671A1 (en) * 2000-09-01 2002-03-13 Neuronyx, Inc. Novel synthetic gangliosides
US9969980B2 (en) * 2001-09-21 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
EP1367395A1 (de) * 2002-05-02 2003-12-03 B.R.A.H.M.S Aktiengesellschaft Diagnose von Neoplasmen mit Hilfe von anti-Gangliosid-Antikörpern
EP1358910A1 (de) * 2002-05-02 2003-11-05 B.R.A.H.M.S Aktiengesellschaft Verfahren und Mittel zur Prävention, Hemmung und Therapie von Krebserkrankungen
US9969977B2 (en) * 2002-09-20 2018-05-15 Garnet Biotherapeutics Cell populations which co-express CD49c and CD90
NZ567841A (en) 2003-03-06 2010-01-29 Seneb Biosciences Inc Methods and compositions for the enzymatic synthesis of gangliosides
JP4965063B2 (ja) * 2004-05-07 2012-07-04 雪印メグミルク株式会社 口腔内細菌叢改善剤、抗菌剤及び生育促進剤。
CN100552315C (zh) 2004-09-23 2009-10-21 国家通风实验室有限公司 混合式通风机
US8354370B2 (en) * 2007-06-15 2013-01-15 Garnet Biotherapeutics, Inc. Administering a biological composition or compositions isolated from self-renewing colony forming somatic cell growth medium to treat diseases and disorders
US20090239834A1 (en) * 2008-03-21 2009-09-24 Braincells, Inc. Mcc-257 modulation of neurogenesis
DE102010024041A1 (de) * 2010-05-16 2013-04-04 Alfred Kroll Symtomfreiheit der Atemwege

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT295036B (de) * 1968-11-29 1971-12-27 Leikola Erkki E Verfahren zur Herstellung von neuen Produkten tierischen Ursprungs
US4125492A (en) * 1974-05-31 1978-11-14 Pedro Cuatrecasas Affinity chromatography of vibrio cholerae enterotoxin-ganglioside polysaccharide and the biological effects of ganglioside-containing soluble polymers
FR2478104B1 (fr) * 1980-03-17 1986-08-08 Merieux Inst Nouveaux derives de gangliosides, leur preparation et leur application
AU542815B2 (en) * 1980-05-09 1985-03-14 Leffler, Hakon Carbohydrate derivatives for inhibiting bacterial adherence
CH658458A5 (fr) * 1981-12-17 1986-11-14 Lucchini Lab Sa Procede pour l'obtention du lacto-n-norhexaosyl ceramide.

Also Published As

Publication number Publication date
US4831021A (en) 1989-05-16
DE3485680D1 (de) 1992-06-04
IT1168205B (it) 1987-05-20
EP0136438A2 (en) 1985-04-10
EP0136438A3 (en) 1987-05-13
US4728641A (en) 1988-03-01
ATE75480T1 (de) 1992-05-15
ES8603191A1 (es) 1985-12-01
DK356984D0 (da) 1984-07-20
ES534494A0 (es) 1985-12-01
HUT35690A (en) 1985-07-29
IT8348724A1 (it) 1985-01-21
JPS6084296A (ja) 1985-05-13
IT8348724A0 (it) 1983-07-21
HU198091B (en) 1989-07-28
EP0136438B1 (en) 1992-04-29
DK356984A (da) 1985-01-22

Similar Documents

Publication Publication Date Title
DK166828B1 (da) Mono-sialo gangliosid gm1p, praeparater indeholdende dette samt anvendelse deraf til fremstilling af et laegemiddel
Takatsuki et al. Tunicamycin, a new antibiotic. III Reversal of the antiviral activity of tunicamycin by aminosugars and their derivatives
SU1318170A3 (ru) Способ получени факторов 1,2,3,4,5 тейхомицина @ и их солей
TSUJI et al. New glycopeptide antibiotics I. The structures of orienticins
US4444753A (en) Pharmaceutical composition comprising extract from poison pouch contents of bee
JPH01157995A (ja) 鎮痛−抗炎症活性を有するガングリオシドの内部エステル
EP0312222B1 (en) Treatment of diseases caused by viruses
DE3782930T2 (de) Neue mittel dc-92b und dc-92d, sowie deren verfahren zur herstellung.
US4892876A (en) Method for inhibiting HIV and an pharmaceutical composition therefor
EP0668289A1 (en) Novel disaccharide derivative
JPH08301772A (ja) 硫酸多糖類のカルシウム塩を含んで成る抗ウイルス剤
EP0890648B1 (en) Non-toxic lipopolysaccharide and its preparation
US5654289A (en) Disaccharide derivative
PT94638A (pt) Processo para a preparacao do antibiotico bu-3889v com actividade antiviral e de composicoes farmaceuticas que o contem
KR100272197B1 (ko) 화합물 ll-e19020 알파1 및 이의 생산방법
CA1129796A (en) Fortimicin factors kg.sub.1, kg.sub.2 and kg.sub.3 and processes for production thereof
US5665779A (en) Pharmaceutical composition for inhibiting the infection with AIDS virus
KR100266472B1 (ko) 화합물ll-e19020엡실론및ll-e19020엡실론1,및이들의생산방법
JP2714665B2 (ja) 抗生物質ｔａｎ−９５０ａおよびその製造法
US4351830A (en) Polymeric compound, MF-300, with protective activity against bacterial infections and its preparation
US5814613A (en) Antibiotic LL-E19020 gamma
JP2890125B2 (ja) 化合物ｔａｎ―１３０７およびその製造法
KR100266470B1 (ko) 화합물ll-e19020제타및화합물ll-e19020에타및그들의생산방법
CN103665069A (zh) 一种氨基糖苷类化合物及其提取分离方法
JPS63264599A (ja) 抗生物質ｔａｎ−８６５およびその製造法

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed